EcoR1 Capital »

Legend Biotech 2 Adr Rep Ord shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $23M 800k 28.88
2021-12-31 $14M 308k 46.61

More positions owned by EcoR1 Capital

Zymeworks Del (ZYME)
Anaptysbio Inc Common (ANAB)
Aktis Oncology (AKTS)
Cg Oncology (CGON)
Eton Pharmaceuticals (ETON)
Crispr Therapeutics Namen Akt (CRSP)
Oric Pharmaceuticals (ORIC)
First Tracks Biotherapeutics Ord Shs Added (TRAX)
Lakefront Biotherapeutics Nv Spon Adr
Neurogene (NGNE)
Stoke Therapeutics (STOK)
Fulcrum Therapeutics (FULC)
Legend Biotech Corp Sponsored Ads (LEGN)
Bridgebio Oncology Therapeut Com New (BBOT)
Mbx Biosciences (MBX)

View all positions for EcoR1 Capital

Top funds holding Legend Biotech 2 Adr Rep Ord

FMR
Deerfield Management Company
Suvretta Capital Management
Hillhouse Capital Advisors
BlackRock
Westfield Capital Management Company
Goldman Sachs Group
Point72 Asset Management
First Beijing Investment
Assenagon Asset Management
Kynam Capital Management
Artisan Partners Limited Partnership
State Street Corporation
Capital Research and Management Company - Division 3
Davern Capital Partners

View all funds holding Legend Biotech 2 Adr Rep Ord